Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03243032Phase 1Withdrawn
Phase 1, randomised, double-blind trial of ibuprofen and bupivacaine in postoperative pain (2 arms). Primary endpoint: Post-operative pain as measured by numerical rating scale at 24 hours. Planned start Oct 2017; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03243032.